Article Text

Download PDFPDF
Triclosan and AMR: missing link
  1. Vaibhav Patwardhan,
  2. Deepak Saxena
  1. Department of Epidemiology, Indian Institute of Public Health Gandhinagar, Gandhinagar, India
  1. Correspondence to Dr Vaibhav Patwardhan, Department of Epidemiology, Indian Institute of Public Health Gandhinagar, Gandhinagar 382042, India; vebhavpatwardhan{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Triclosan (TCS) and triclocarban are a group of chemicals that pose microbicidal properties and can perform bacteriostatic and fungistatic activities. Because of these properties, the applications of TCS are not only limited to the healthcare industry but are also being widely used in cosmetic and personal hygiene products. Lately, TCS has been used in a wide range of daily-use products (antibacterial toothpaste, hand sanitisers, soaps, hand washes, deodorants and others) to enhance the substance’s antimicrobial and ‘germ-free’ properties.1 This wide use of TCS in day-to-day products has also raised several concerns over the adverse impacts on health. TCS is also known for its stable nature, and it can survive in the residential drains and sewage treatment plants for longer periods.2 This constant interaction of TCS with faecal microbes of wastewater may further have undesired outcomes including antibiotic resistance. The US Food and Drug Administration realised the severity of …

View Full Text

Footnotes

  • Contributors VP conceptualised the study, undertook the data extraction, prepared the draft manuscript and contributed to the final submission of the study. DS contributed to the manuscript preparation and reviewed the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.